FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics and represents a controlled-release aceclofenac preparation for oral administration once a day, exhibiting the fast analgesic and anti-inflammatory action, containing a fast-release layer containing aceclofenac, a solubiliser, a water-soluble additive, a disintegrating agent, a vehicle and a fast-acting additive, as well as a sustained-release layer containing aceclofenac, a solubiliser and a release control base consisting of mixture of hydroxypropyl methyl cellulose (HPMC) with a viscosity of 80,000 sP to 120,000 sP and carbomer taken in mass ratio 7:1 to 9:1.
EFFECT: invention provides a sequential and uniform dissolution rate and a controlled release of the active agent.
7 cl, 12 tbl, 11 dwg, 10 ex
Title | Year | Author | Number |
---|---|---|---|
SUSTAINED RELEASE PILL, CONTAINING LEVODROPROPIZINE, AND MANUFACTURING METHOD THEREOF | 2013 |
|
RU2616263C2 |
ACECLOFENAC-CONTAINING CONTROL RELEASE ORAL DOSAGE FORMS AND METHOD FOR PREPARING THEM | 2009 |
|
RU2493843C2 |
ACECLOFENAC-CONTAINING PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCTION THEREOF | 2020 |
|
RU2781641C1 |
ORAL PREPARATION WITH SUSTAINED RELEASE | 2015 |
|
RU2696870C2 |
SUSTAINED-RELEASE PHARMACEUTICAL COMPOSITION CONTAINING RIVASTIGMINE | 2016 |
|
RU2727721C2 |
METHODS FOR PREPARING ERGOT ALKALOIDS PHARMACEUTICAL COMPOSITIONS WITH PROLONGED EFFECT CHARACTERIZING WITH IMPROVED BIOAVAILABILITY AND COMPOSITIONS COMPRISING INDICATED ALKALOIDS | 2000 |
|
RU2256454C2 |
PROLONGED ACTION PREPARATION OF DICLOFENAC SODIUM | 2002 |
|
RU2221559C1 |
LENALIDOMIDE TABLET COMPOSITION FOR ORAL ADMINISTRATION | 2017 |
|
RU2725074C1 |
PHARMACEUTICAL COMPOSITION WITH ANTICONVULSIVE AND PSYCHOTROPIC ACTION | 2007 |
|
RU2342144C1 |
PHARMACEUTICAL COMPOSITIONS CONTAINING DIACEREIN | 2009 |
|
RU2542461C2 |
Authors
Dates
2015-02-10—Published
2011-06-01—Filed